Newsfeeds - Spark Newswire

2 minute read

Legal
News

U.S. Patent and Trademark Office Rejects Axonics’ Challenge to Medtronic Patents

Today, 2:49 PM

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has won three additional important victories in a dispute over its intellectual property (IP) for its sacral

AXNX

4 minute read

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

By Shanthi Rexaline

Today, 2:49 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9)

ABSI

5 minute read

The Daily Biotech Pulse: MacroGenics’ Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA’s FDA Nod

By Shanthi Rexaline

Today, 2:49 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7)

ADIL

3 minute read

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself

By Shanthi Rexaline

Today, 2:49 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2)

ABT

5 minute read

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

By Shanthi Rexaline

Today, 2:49 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)

ABBV

5 minute read

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical

By Shanthi Rexaline

Today, 2:49 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26)

ABSI

2 minute read

Earnings

Looking into Axonics Modulation Tech’s Return on Capital Employed

By Benzinga Insights

Today, 2:49 PM

After pulling data from Benzinga Pro it seems like during Q2, Axonics Modulation Tech (NASDAQ:AXNX) posted sales of $45.87 million. Earnings were up 25.93%, but Axonics Modulation Tech still reported an overall loss of $16.01 million.

AXNX